American Shared Hospital Services' first quarter told two stories, and on the surface they look like they could not both be true. The first story is operational: total revenue rose 15.9% to $7.1 million, driven by a 30.2% jump in the direct-patient-services segment that houses the Rhode Island and Puebla radiation-therapy facilities; gross margin expanded roughly 270 basis points to 18.2%, lifted by improving utilization; the GAAP operating loss narrowed by 29% to roughly $(0.9) million; and adjusted EBITDA rose 18.4% to $1.1 million, the strongest first-quarter cash-earnings print in three years. The second story is structural: the company is in active going-concern doubt, the $22 million Fifth Third credit facility matured on April 9, 2026 with no repayment, and three financial-covenant defaults remain uncured. Without an out, the auditors said, the company does not have enough cash on hand to satisfy an accelerated demand.
The out arrived on July 22, 2026 and is the single most important fact about this company right now. American Shared Hospital Services entered a Third Amendment and Forbearance Agreement with Fifth Third that imposes a Standstill Period running through June 30, 2027, during which the lender will not accelerate the obligations. In exchange the company must, every month, sweep any excess cash flow above $5 million into the loan, prepay $200,000 a quarter on the term loans, and - the new and binding obligation - pursue the sale of all or a portion of the company and its assets on a milestone schedule that terminates the standstill if not met. A $2 million subordinated note from a related party (the Executive Chairman's holding company) and 220,000 warrants at a $1.45 strike, deposited into a blocked account, sit alongside the forbearance. The runway is real but defined: roughly eleven months, in exchange for an asset-sale track.
The stock trades at $1.53 against a 52-week band of $1.25 to $3.11, giving a market capitalization of roughly $10 million on 6.63 million shares - a company whose $15.4 million of senior secured debt plus the new $2 million sub note more than covers the entire equity value, and whose $5.2 million of cash and equivalents at quarter-end is one-quarter of the $16.8 million of current-debt obligations carried on the balance sheet. Adjusted EBITDA of $1.1 million in a single quarter, multiplied by four, is roughly $4.4 million - and the lender's $5 million minimum-unrestricted-cash floor has just been relaxed for the standstill window. The market is pricing the operational turn against the financing wall, and the forbearance is the bridge that lets the turn matter. The thesis from here is the sale process, not the operating run rate.